Molecular pathology assists the diagnosis of lymphoepithelial sialadenitis, Sjögren's syndrome and extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue.

[1]  S. Swerdlow,et al.  IRTA1 positivity helps identify a MALT‐lymphoma‐like subset of primary cutaneous marginal zone lymphomas, largely but not exclusively defined by IgM expression , 2021, Journal of cutaneous pathology.

[2]  Jun Zhu,et al.  Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for malignant lymphoma 2021 (English version) , 2021, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.

[3]  A. Vissink,et al.  Gene expression profiling of epithelium-associated FcRL4+ B cells in primary Sjögren’s syndrome reveals a pathogenic signature , 2020, Journal of autoimmunity.

[4]  A. Salar,et al.  Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Toru Nakamura,et al.  Primary thymic MALT lymphoma in a patient with Sjögren’s syndrome and multiple lung cysts: a case report , 2019, Surgical Case Reports.

[6]  K. Stamatopoulos,et al.  Next-generation sequencing of immunoglobulin gene rearrangements for clonality assessment: a technical feasibility study by EuroClonality-NGS , 2019, Leukemia.

[7]  M. Koutsilieris,et al.  TNFAIP3 F127C Coding Variation in Greek Primary Sjogren's Syndrome Patients , 2018, Journal of immunology research.

[8]  E. Mardis,et al.  Next-Generation Sequencing Technologies. , 2018, Cold Spring Harbor perspectives in medicine.

[9]  J. Cook,et al.  IRTA1 and MNDA Expression in Marginal Zone Lymphoma: Utility in Differential Diagnosis and Implications for Classification , 2018, American Journal of Clinical Pathology.

[10]  Dan Yu,et al.  Evaluation of the diagnostic value of immunoglobulin clonal gene rearrangements in patients with parotid gland MALT lymphoma using BIOMED-2 protocol. , 2018, Oral surgery, oral medicine, oral pathology and oral radiology.

[11]  A. Vissink,et al.  FcRL4+ B-cells in salivary glands of primary Sjögren's syndrome patients. , 2017, Journal of autoimmunity.

[12]  N. Nikitakis,et al.  MALT Lymphoma of Minor Salivary Glands in a Sjögren’s Syndrome Patient: a Case Report and Review of Literature , 2017, Journal of oral & maxillofacial research.

[13]  L. Criswell,et al.  2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome , 2016, Annals of the rheumatic diseases.

[14]  B. Treanor,et al.  Involvement of the HCK and FGR src-Family Kinases in FCRL4-Mediated Immune Regulation , 2015, The Journal of Immunology.

[15]  E. Sakhinia,et al.  Probing PARP1-inhibitor complexes for the development of novel inhibitors. , 2014, Cellular and molecular biology.

[16]  S. Pileri,et al.  IRTA1 is selectively expressed in nodal and extranodal marginal zone lymphomas , 2012, Histopathology.

[17]  E. Schuuring,et al.  EuroClonality/BIOMED-2 guidelines for interpretation and reporting of Ig/TCR clonality testing in suspected lymphoproliferations , 2012, Leukemia.

[18]  G. Gaidano,et al.  Clinical and molecular features of mucosa‐associated lymphoid tissue (MALT) lymphomas of salivary glands , 2009, Head & neck.

[19]  H. Noels,et al.  The pathogenesis of MALT lymphomas: where do we stand? , 2007, Leukemia.

[20]  A. Ebens,et al.  Expression pattern of the human FcRH/IRTA receptors in normal tissue and in B-chronic lymphocytic leukemia. , 2006, International immunology.

[21]  M Hummel,et al.  Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.

[22]  L. Pasqualucci,et al.  Expression of the IRTA1 receptor identifies intraepithelial and subepithelial marginal zone B cells of the mucosa-associated lymphoid tissue (MALT). , 2003, Blood.

[23]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[24]  L. Weiss,et al.  Assessment of clonality in lymphoid proliferations. , 1993, The American journal of pathology.

[25]  H. Stein,et al.  T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution. , 2005, Haematologica.

[26]  N. Harris Lymphoid proliferations of the salivary glands. , 1999, American journal of clinical pathology.